Advertisements


We are Sorry, This Page doesn't Exist


The Daily Biotech Pulse: Celyad To Advance Leukemia Drug To Clinical Trial, Positive Data For Teva"s Migraine Drug

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on July 1) read more.....»»

Category: blogSource: benzingaJul 2nd, 2019

2 Warren Buffett Stocks Tumble to 52-Week Lows

Buffett-approved stocks at lower-than-Buffett's pricesCheck out Warren Buffett Stock Picks » Download GuruFolio Report of Warren Buffett (Updated on 06/17/2019)Related Stocks: KHC, TEVA, XLF, WFC, BRK.A, BRK.B, XLV,.....»»

Category: worldSource: nytJun 18th, 2019

6 Warren Buffett Holdings Near 52-Week Lows

Market remains significantly overvalued ahead of Memorial DayCheck out Warren Buffett Stock Picks » Download GuruFolio Report of Warren Buffett (Updated on 05/23/2019)Related Stocks: AAPL, BRK.A, BRK.B, KHC, DVA, TEVA, SIRI, AAL, BK,.....»»

Category: blogSource: gurufocusMay 24th, 2019

Options Traders Making Big Long-Term Bets On Teva

Teva Pharmaceutical Industries Ltd (NYSE: TEVA) shares were rocked this week after 44 different states filed a lawsuit against the company alleging Teva was among 2 read more.....»»

Category: blogSource: benzingaMay 14th, 2019

Teva puts active as shares tumble to 52-week lows

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 13th, 2019

The Daily Biotech Pulse: Mixed Results For Merck"s Keytruda In Stomach Cancer; Roche"s Spark-Buy Delayed, Teva Recalls Hypertension Drug

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on April 25) read more.....»»

Category: blogSource: benzingaApr 26th, 2019

Insider Buys Of The Week: ADS, Tesla, Teva And More

Insider buying can be an encouraging signal for potential investors. The CEO of the leading electric vehicle maker put his money where his mouth is this week. A couple of 10 percent owners notably increased their stakes as well. read more.....»»

Category: blogSource: benzingaMay 13th, 2018

Benzinga"s Daily Biotech Pulse: Biomarin Gets FDA Nod, Amarin Settles with Teva, Merck"s Cancer Drug Review Extended

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks Here are the biotech stocks that were hitting 52-week highs May 24:  ArQule, Inc. (NASDAQ: ARQL) read more.....»»

Category: blogSource: benzingaMay 25th, 2018

Bullish option play in Teva ahead of earnings next week

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 27th, 2018

Generic EpiPen may not launch in time for allergic kids going back to school

When Teva Pharmaceutical Industries Ltd.'s generic version of the EpiPen allergic reaction treatment was approved last week, amid spot shortages of the branded product and concerns about allergic children ne.....»»

Category: topSource: marketwatchAug 24th, 2018

Put buyer in Teva Pharmaceuticals appears to adjust week-old position

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 18th, 2018

The Daily Biotech Pulse: Teva Settles With FTC, Setback For Merck In Liver Cancer Trial, Sienna Biopharma Offering

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting 52-week highs on Feb. 19) read more.....»»

Category: blogSource: benzingaFeb 20th, 2019

The Daily Biotech Pulse: Teva Settles With FTC, Setback For Merck In Liver Cancer Trial, Sienna Biopharma Offering

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting 52-week highs on Feb. 19) Alector Inc (NASDAQ: ALEC) (IPOed early Febru.....»»

Category: earningsSource: benzingaFeb 20th, 2019

Why AI Leader Nvidia Dipped More Than 10% This Week

AI phenomenon Nvidia (Nasdaq: NVDA) got the wind taken out of its sails this week.....»»

Category: personnelSource: nyt1 hr. 21 min. ago

Mortgage Interest Rates Today, April 20, 2024 | Rates Remain Elevated, but They Could Fall Later This Year

These are today's mortgage and refinance rates. Mortgage rates are holding steady around 7% after spiking last week in response to .....»»

Category: worldSource: nyt4 hr. 9 min. ago

The Largest Companies Paying Dividends This Week

Welcome to your quick hit of the biggest players on the block paying out dividends in the coming week. Let’s dive right in and spotlight some of the giants! First up, we have Oracle (ORCL). Oracle, the powerhouse behi.....»»

Category: worldSource: nyt17 hr. 21 min. ago

Bitcoin, Ethereum, Dogecoin Pick Up Steam: The Pre-Halving Week In Retrospect

Cr.....»»

Category: blogSource: benzinga18 hr. 53 min. ago

US Domestic Bank Deposits Drop For Second Straight Week

US Domestic Bank Deposits Drop For Second Straight Week On the heels of a maj.....»»

Category: dealsSource: nyt19 hr. 21 min. ago

Cryptocurrency NEAR Protocol Down More Than 3% Within 24 hours

Over the past 24 hours, NEAR Protocol's (CRYPTO: NEAR) price has fallen 3.53% to $5.6. This continues its negative trend over the past week where it has experienced a 15.0% loss, moving from $6.56 to its current price. read more.....»»

Category: blogSource: benzingaApr 19th, 2024

Here"s what Cleveland-Cliffs CEO Lourenco Goncalves said about the US Steel deal

Cleveland-Cliffs CEO Lourenco Goncalves predicted last week that not only will Nippon Steel fall short in its bid to acquire United States Steel but that he'll be there to successfully acquire the Pittsburgh-based manufacturer......»»

Category: topSource: bizjournalsApr 19th, 2024